Spyre Therapeutics
SYRE
SYRE
83 hedge funds and large institutions have $95.4M invested in Spyre Therapeutics in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
50% less capital invested
Capital invested by funds: $189M → $95.4M (-$93.9M)
Holders
83
Holding in Top 10
2
Calls
$3K
Puts
–
Top Buyers
| 1 | +$3.42M | |
| 2 | +$1.58M | |
| 3 | +$1.13M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$890K |
| 5 |
SCM
Sio Capital Management
New York
|
+$857K |
Top Sellers
| 1 | -$4.96M | |
| 2 | -$4.75M | |
| 3 | -$4.32M | |
| 4 |
Axa
Paris,
France
|
-$2.11M |
| 5 |
ACM
Altium Capital Management
New York
|
-$1.4M |